1
|
Baska F, Bozó É, Szeleczky Z, Szántó G, Vukics K, Szakács Z, Domány-Kovács K, Kurkó D, Vass E, Thán M, Vastag M, Temesvári K, Lévai S, Halász AS, Szondiné Kordás K, Román V, Greiner I, Bata I. Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist. J Med Chem 2024; 67:643-673. [PMID: 38165765 DOI: 10.1021/acs.jmedchem.3c01868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2024]
Abstract
The V1a receptor is a major contributor in mediating the social and emotional effects of arginine-vasopressin (AVP); therefore it represents a promising target in the treatment of several neuropsychiatric conditions. The aim of this research was to design and synthesize novel and selective V1a antagonists with improved in vitro and in vivo profiles. Through optimization and detailed SAR studies, we developed low nanomolar antagonists, and further characterizations led to the discovery of the clinical candidate compound 43 (RGH-122). The CNS activity of the compound was determined in a 3-chamber social preference test of autism in which RGH-122 successfully enhanced social preference with the lowest effective dose of 1.5 mg/kg.
Collapse
Affiliation(s)
- Ferenc Baska
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | - Éva Bozó
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | | | - Gábor Szántó
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | | | | | | | - Dalma Kurkó
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | - Elemér Vass
- Institute of Chemistry, Eötvös Loránd University, Pázmány Péter sétány 1/A, Budapest H-1117, Hungary
| | - Márta Thán
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | - Mónika Vastag
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | | | - Sándor Lévai
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | | | | | - Viktor Román
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| | | | - Imre Bata
- Gedeon Richter Plc, PO Box 27, Budapest H-1475, Hungary
| |
Collapse
|
2
|
Szeleczky Z, Szakács Z, Bozó É, Baska F, Vukics K, Lévai S, Temesvári K, Vass E, Béni Z, Krámos B, Magdó I, Szántay C, Kóti J, Domány-Kovács K, Greiner I, Bata I. Synthesis and Characterization of New V 1A Antagonist Compounds: The Separation of Four Atropisomeric Stereoisomers. J Med Chem 2021; 64:10445-10468. [PMID: 34255509 DOI: 10.1021/acs.jmedchem.1c00863] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
A new class of selective vasopressin receptor 1A (V1A) antagonists was identified, where "methyl-scan" was performed around the benzene ring of the 5-hydroxy-triazolobenzazepine core. This led to the synthesis of two 10-methyl derivatives, each possessing a chiral axis and a stereogenic center. The four atropisomeric stereoisomers (involving two enantiomer pairs and atropisomeric diastereomers) could be successfully isolated and spectroscopically characterized. According to the in vitro pharmacological profiles of the compounds, the human V1A receptor has a strong preference toward the isomers having an aR axial chirality, the most active isomer being the aR,5S isomer. Furthermore, the structure-activity relationships obtained for the isomers and for the newly synthesized analogues could be tentatively explained by an in silico study.
Collapse
Affiliation(s)
- Zsolt Szeleczky
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Zoltán Szakács
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Éva Bozó
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Ferenc Baska
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | | | - Sándor Lévai
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | | | - Elemér Vass
- Institute of Chemistry, Eötvös Loránd University, Pázmány Péter sétány 1/A, Budapest H-1117, Hungary
| | - Zoltán Béni
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Balázs Krámos
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Ildikó Magdó
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Csaba Szántay
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - János Kóti
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | | | - István Greiner
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| | - Imre Bata
- Gedeon Richter Plc., 19-21 Gyömrői út, Budapest 1103, Hungary
| |
Collapse
|
3
|
Baska F, Szántó G, Bozó É, Szakács Z, Dékány M, Szondiné Kordás K, Domány-Kovács K, Kurkó D, Hodoscsek B, Magdó I, Krámos B, Béni Z, Vastag M, Bata I. Discovery of New Heterocyclic Ring Systems as Novel and Potent V 1A Receptor Antagonists. ACS Chem Neurosci 2020; 11:3532-3540. [PMID: 33084311 DOI: 10.1021/acschemneuro.0c00486] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Autism spectrum disorder is a neurodevelopmental disease with increasing occurrence. Recent studies focus on the development of novel V1A receptor antagonists which can influence the core symptoms of autism through the AVP pathway. In this study, we describe the synthesis of new heterocyclic ring systems. These are a novel class of brain-penetrating V1A antagonists with improved metabolic stability and in vivo potency. The efficacy of the compounds was strongly influenced by the position of the chlorine atom, suggesting halogen bond formation between the ligands and the V1A receptor.
Collapse
Key Words
- ASD
- CNS
- V1A receptor
- halogen bonding
- imidazo[1,2-a][1,2,4]triazolo[4,3-c][1,3]diazepine
- imidazo[1,2-a][1,2,4]triazolo[4,3-c][1,3]diazocine
Collapse
Affiliation(s)
- Ferenc Baska
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Gábor Szántó
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Éva Bozó
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Zoltán Szakács
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Miklós Dékány
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | | | | | - Dalma Kurkó
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Barbara Hodoscsek
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Ildikó Magdó
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Balázs Krámos
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Zoltán Béni
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Mónika Vastag
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| | - Imre Bata
- Gedeon Richter Plc, Budapest 10, PO Box 27, Budapest H-1475, Hungary
| |
Collapse
|